Denmark· DK-28107170624
Omvoh
A mirikizumab product containing mirikizumab, registered in Denmark by Eli Lilly Nederland B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Mirikizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AC24 (mirikizumab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Mirikizumab · ATC L04AC24
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mirikizumab costs, country by country.
Normalised to the WHO defined daily dose (7.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mirikizumab · price per daily dose (7.1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$30.99
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Mirikizumab
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Denmark (DK)
- ATC code
- L04AC24
- ATC class
- Mirikizumab
- Defined daily dose
- 7.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107170624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L04AC24
Mirikizumab, as other registers publish it.
- United StatesOmvohEli Lilly and Company
- FinlandOmvohEli Lilly Nederland B.V.
- United StatesOmvohEli Lilly and Company
- United StatesOmvohEli Lilly and Company
- United StatesOmvohEli Lilly and Company
- United StatesOmvohEli Lilly and Company
- United StatesOmvohEli Lilly and Company
- FinlandOmvohEli Lilly Nederland B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2dfaa07-62aa-4b5e-af0a-9eb27fa519a8 GET /v1/drugs/f2dfaa07-62aa-4b5e-af0a-9eb27fa519a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning i fyldt injektionssprøjte",
"source": "dkma",
"strength": "200 mg + 100 mg",
"auth_role": "MOD",
"dk_drugid": "28107170624",
"substance": "Mirikizumab",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "45700"
}See everything about mirikizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.